| Literature DB >> 25810545 |
Ryosuke Kobayashi1, Akihisa Kato1, Shinya Oda2, Naoto Koyanagi1, Masaaki Oyama3, Hiroko Kozuka-Hata3, Jun Arii1, Yasushi Kawaguchi4.
Abstract
Replacement of the herpes simplex virus 1 small capsid protein VP26 phosphorylation site Thr-111 with alanine reduced viral replication and neurovirulence to levels observed with the VP26 null mutation. This mutation reduced VP26 expression and mislocalized VP26 and its binding partner, the major capsid protein VP5, in the nucleus. VP5 mislocalization was also observed with the VP26 null mutation. Thus, we postulate that phosphorylation of VP26 at Thr-111 regulates VP26 function in vitro and in vivo.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25810545 PMCID: PMC4442450 DOI: 10.1128/JVI.00547-15
Source DB: PubMed Journal: J Virol ISSN: 0022-538X Impact factor: 5.103